Review Special Issues

Thermal analysis of ligand-DNA interaction: determination of binding parameters

  • The review discusses the methods of thermodynamic analysis of reactions of non-covalent binding of biologically active compounds with DNA, which is a key constituent of cell chromatin. Knowledge of thermodynamic profile of ligand binding with nucleic acids is important for understanding the mechanism of medico-biological action of the currently existing drugs and for designing of new drugs with improved medical effect. Thermodynamic analysis of ligand binding with DNA is based on analysis of experimentally measured changes of Gibbs free energy (ΔG), enthalpy (ΔH), entropy (ΔS) and heat capacity (ΔCр). Right selection of the methods of measurement of these parameters and understanding of limitations of currently existing approaches for numerical data analysis are crucially important for correct interpretation of the obtained results and getting insight into the mechanism of drug-DNA interaction. In the present work the currently existing methods of determination of thermodynamic parameters of ligand binding with DNA were divided into two main groups. The first group is associated with the approaches used in cases when the heating of the system does not cause melting of the biopolymer. The main focus is given to the second group of the methods which are based on description of helix-coil transition of DNA-ligand complexes with further comparison of the same transition for «free» biopolymer. The methods of computation of the binding parameters utilizing the Ising-type models and models based on the equations of chemical equilibrium are discussed.

    Citation: Ekaterina Bereznyak, Natalia Gladkovskaya, Evgeniy Dukhopelnykov, Anastasiya Gerus, Anastasiya Lantushenko, Maxim Evstigneev. Thermal analysis of ligand-DNA interaction: determination of binding parameters[J]. AIMS Biophysics, 2015, 2(4): 423-440. doi: 10.3934/biophy.2015.4.423

    Related Papers:

    [1] Hui Zhou, Bo Lu, Huaguang Gu, Xianjun Wang, Yifan Liu . Complex nonlinear dynamics of bursting of thalamic neurons related to Parkinson's disease. Electronic Research Archive, 2024, 32(1): 109-133. doi: 10.3934/era.2024006
    [2] Zilu Cao, Lin Du, Honghui Zhang, Lianghui Qu, Luyao Yan, Zichen Deng . Firing activities and magnetic stimulation effects in a Cortico-basal ganglia-thalamus neural network. Electronic Research Archive, 2022, 30(6): 2054-2074. doi: 10.3934/era.2022104
    [3] Yapeng Zhang, Yu Chen, Quanbao Ji . Dynamical analysis of spontaneous Ca2+ oscillations in astrocytes. Electronic Research Archive, 2024, 32(1): 405-417. doi: 10.3934/era.2024020
    [4] Xia Shi, Ziheng Zhang . Multiple-site deep brain stimulation with delayed rectangular waveforms for Parkinson's disease. Electronic Research Archive, 2021, 29(5): 3471-3487. doi: 10.3934/era.2021048
    [5] Feibiao Zhan, Jian Song, Shenquan Liu . The influence of synaptic strength and noise on the robustness of central pattern generator. Electronic Research Archive, 2024, 32(1): 686-706. doi: 10.3934/era.2024033
    [6] Chengtian Ouyang, Huichuang Wu, Jiaying Shen, Yangyang Zheng, Rui Li, Yilin Yao, Lin Zhang . IEDO-net: Optimized Resnet50 for the classification of COVID-19. Electronic Research Archive, 2023, 31(12): 7578-7601. doi: 10.3934/era.2023383
    [7] Honghui Zhang, Yuzhi Zhao, Zhuan Shen, Fangyue Chen, Zilu Cao, Wenxuan Shan . Control analysis of optogenetics and deep brain stimulation targeting basal ganglia for Parkinson's disease. Electronic Research Archive, 2022, 30(6): 2263-2282. doi: 10.3934/era.2022115
    [8] Ping Wang, Changgui Gu, Huijiu Yang, Haiying Wang . Identify the characteristic in the evolution of the causality between the gold and dollar. Electronic Research Archive, 2022, 30(10): 3660-3678. doi: 10.3934/era.2022187
    [9] Ariel Leslie, Jianzhong Su . Modeling and simulation of a network of neurons regarding Glucose Transporter Deficiency induced epileptic seizures. Electronic Research Archive, 2022, 30(5): 1813-1835. doi: 10.3934/era.2022092
    [10] Yi Chen, Benhuan Nie, Zhehao Huang, Changhong Zhang . Spatial relevancy of digital finance in the urban agglomeration of Pearl River Delta and the influence factors. Electronic Research Archive, 2023, 31(8): 4378-4405. doi: 10.3934/era.2023224
  • The review discusses the methods of thermodynamic analysis of reactions of non-covalent binding of biologically active compounds with DNA, which is a key constituent of cell chromatin. Knowledge of thermodynamic profile of ligand binding with nucleic acids is important for understanding the mechanism of medico-biological action of the currently existing drugs and for designing of new drugs with improved medical effect. Thermodynamic analysis of ligand binding with DNA is based on analysis of experimentally measured changes of Gibbs free energy (ΔG), enthalpy (ΔH), entropy (ΔS) and heat capacity (ΔCр). Right selection of the methods of measurement of these parameters and understanding of limitations of currently existing approaches for numerical data analysis are crucially important for correct interpretation of the obtained results and getting insight into the mechanism of drug-DNA interaction. In the present work the currently existing methods of determination of thermodynamic parameters of ligand binding with DNA were divided into two main groups. The first group is associated with the approaches used in cases when the heating of the system does not cause melting of the biopolymer. The main focus is given to the second group of the methods which are based on description of helix-coil transition of DNA-ligand complexes with further comparison of the same transition for «free» biopolymer. The methods of computation of the binding parameters utilizing the Ising-type models and models based on the equations of chemical equilibrium are discussed.


    Parkinson's disease (PD) is a common degenerative disease of the nervous system. The physiological trigger is mainly the degeneration and death of dopaminergic neurons in the substantia nigra pars compacta, though the exact cause is still unclear [1]. The mechanism is relatively complex; therefore, the study of the pathological mechanism and clinical control of PD are key scientific issues in related fields at home and abroad.

    The dynamic characterization of PD mainly reflects the discharge mode. Specifically, there is a significant increase in the proportion of cluster discharges in action potentials of neurons in the PD state, as well as an increased synchrony between adjacent neurons [2]. In the normal state, neurons discharge randomly, showing a chaotic state, and usually do not produce cluster discharge behavior, which is closely related to the severity of the disease in PD patients. In addition, an analysis of local field potential signals recorded by deep brain stimulation (DBS) electrodes in PD patients found that the relative power in the beta frequency band (13–30 Hz) in PD patients was higher than in the normal state [3]. Unit neuron activity and local field potentials recorded from the basal ganglia of PD animals and patients showed changes in oscillatory behaviors that could interfere with information processing in the basal ganglia and cause motor dysfunction.

    Current dynamic models of PD are mainly limited to neuronal populations and rarely consider astrocytes. However, increasing evidence suggests that astrocytes play an important role in numerous neurodegenerative diseases, such as PD [4,5,6]. Astrocytes are the most abundant cells in the central nervous system (CNS) and are involved in maintaining the physiological functions of the CNS. When the body is stimulated, microglia are the first to activate, secrete pro-inflammatory factors, and act on astrocytes. Astrocytes amplify the inflammatory response mediated by microglia and release more pro-inflammatory factors, thus forming a vicious feedback loop. Activated astrocytes not only aggravate the amplification of inflammatory signals, but also produce glutamate and oxidative stress products, thus mediating the death of dopaminergic neurons [7]. Moreover, astrocytes promote the establishment and maturation of synaptic structures by releasing a variety of factors, while enhancing synaptic transmission by regulating the distribution of glutamate receptors. In addition, they can participate in the elimination of synapses through direct and indirect mechanisms[8]. Moreover, recent studies have highlighted the impact of astrocytes on neuronal circuits and synaptic functions in PD [9,10,11,12]. Iovino et al. suggested that any neuroprotective loss of astrocytes or gains in neurotoxic phenotypes could lead to glutamate-mediated PD toxicity [5]. Brandebura et al. pointed out that astrocytes are key players in PD, which is characterized by altered synaptic function, synaptic loss, and neuronal death [13]. Theoretical research on the involvement of glial cells in disease models has begun to emerge [14]. Among them, highly simplified astrocyte models, such as the "tripartite synapse", have achieved accuracy and predictability of ion concentration dynamics such as calcium, sodium, and potassium [15,16,17]. Mathematical modeling of the interaction mechanisms between neurons and astrocytes suggested that astrocytes could contribute to the generation of epileptiform discharges by directly affecting the excitatory/inhibitory balance of neuronal networks [18]. However, few studies have considered the mechanism of astrocyte involvement in PD from a theoretical perspective. Employing dynamic modeling helps reveal the role of astrocytes in PD circuits, thus offering comprehensive insights into the mechanisms and potential therapeutic avenues for PD.

    Inspired by these findings, this paper focuses on investigating the influence of astrocytes on the PD-related neural circuit (i.e., the subthalamic nucleus - globus pallidus (STN-GPe) model). Sections 2–4 provide a dynamical description of the proposed model, the main results, and the conclusions and discussions, respectively.

    The STN-GPe model plays a vital pacemaker role in the basal ganglia, which is highly correlated with the generation of PD-associated discharge patterns. Therefore, we will adopt the model proposed in [19]. It can simulate a variety of discharge waveforms, some of which correspond to the synchronous oscillatory activity patterns observed in patients with PD, which are thought to be associated with symptoms of hypokinesia [20,21]. Below is a brief description of the equations for each population [19]:

    $ CmvSTN=ILINaIKITICaIAHPIGPeSTN,
    $
    (2.1)
    $ CmvGPe=ILINaIKITICaIAHPISTNGPeIGPeGPe+Iapp.
    $
    (2.2)

    Here, $ C_{m} = 1 pF/ \mu m^{2} $. $ I_{L} $, $ I_{N a} $, and $ I_{K} $ are the leak, sodium, and potassium ion currents, respectively. The current $ I_{T} $ is a low-threshold T-type calcium current. $ I_{Ca} $ is a high-threshold calcium current. $ I_{AHP} $ is a $ Ca^{2+} $-activated, voltage-independent afterhyperpolarization $ K^{+} $ current. $ I_{G Pe \rightarrow STN} $ represents the synaptic current from the GPe to the STN, which is similar to $ I_{STN \rightarrow GPe} $ and $ I_{GPe \rightarrow GPe} $. $ I_{app} $ is a constant bias current. For more details, please refer to the reference [19].

    Currently, some classical models have been proposed to simulate the dynamics of the intracellular $ Ca^{2+} $ concentration, among which the Li-Rinzel model is more commonly used, which can be expressed by the following equations:

    $ d[Ca2+]dt=JchanJpump+Jleak,
    $
    (2.3)
    $ dqdt=αq(1q)βqq,
    $
    (2.4)
    $ Jchan=c1v1p3n3q3([Ca2+]ER[Ca2+]),
    $
    (2.5)
    $ Jpump=v3[Ca2+]2[Ca2+]2+k23,
    $
    (2.6)
    $ Jleak=c1v2([Ca2+]ER[Ca2+]),
    $
    (2.7)
    $ p=[IP3][IP3]+d1,
    $
    (2.8)
    $ n=[Ca2+][Ca2+]+d4,
    $
    (2.9)
    $ αq=a1d2[IP3]+d1[IP3]+d3,
    $
    (2.10)
    $ βq=a1[Ca2+],
    $
    (2.11)
    $ [Ca2+]ER=c0[Ca2+]c1,
    $
    (2.12)

    where $ [Ca^{2+}] $ denotes the cytosolic calcium concentration that varies in the time domain, and $ q $ is the fraction of activated IP3 receptors. $ J_{chan} $, $ J_{pump} $, and $ J_{leak} $ are the endoplasmic reticulum (ER)-to-cytosol calcium flux, the cytoplasm-to-ER pump flux, and the ER-to-cytosol leakage flux, respectively. $ [Ca^{2+}]_{ER} $ is the calcium ion concentration in the ER. $ p_\infty $ and $ n_\infty $ are the calcium channel gated activation variables dependent on the IP3 concentration and the calcium ion concentration, respectively. $ \alpha_q $ and $ \beta_q $ refer the activation and inactivation rates of the IP3 receptor channels, respectively. $ [IP_{3}] $ indicates the production of intracellular IP3 in the astrocyte, which is modeled by the following:

    $ d[IP3]dt=[IP3][IP3]τip3+rip3([T]STN+[T]GPe),
    $
    (2.13)

    where $ [IP_{3}^*] $ is the equilibrium concentration of IP3. $ \tau_{ip3} $ refers to a decay in the intracellular IP3 concentration. The parameter $ r_{ip3} $ determines the rate of IP3 production in response to a neuronal action potential. $ [T]_{STN} $/$ [T]_{GPe} $ represents the concentration of neurotransmitters released from the STN/GPe neuron to the synaptic cleft.

    Table 1.  Parameter value of astrocyte model.
    Symbol Value Symbol Value
    $ [Ca^{2+}]_{th} $ 0.2 $ \mu $M $ v_1 $ 6 s$ ^{-1} $
    $ \tau_{Ca^{2+}} $ 6 s $ v_2 $ 0.11 s$ ^{-1} $
    $ \tau_{ip_{3}} $ 7 s $ v_3 $ 0.9 $ \mu $Ms$ ^{-1} $
    $ r_{ip_{3}} $ 7.2 $ \mu $Ms$ ^{-1} $ $ d_1 $ 0.13 $ \mu $M
    $ [IP^{*}_{3}] $ 0.16 $ \mu $M $ d_2 $ 1.05 $ \mu $M
    $ c_0 $ 2 $ \mu $M $ d_3 $ 0.94 $ \mu $M
    $ c_1 $ 0.185 $ d_4 $ 0.082 $ \mu $M
    $ k_3 $ 0.1 $ \mu $M $ k $ 0.5 s$ ^{-1} $
    $ a_1 $ 0.2 $ \mu $M$ ^{-1} $ s$ ^{-1} $

     | Show Table
    DownLoad: CSV

    Referring to the work of Volman et al. [22], the dynamic variable $ f $ is used to capture the interaction between neurons and astrocytes. Specifically, when the calcium concentration in the astrocytes exceeds a threshold value, a limited number of glial transmitters are released into the synaptic space, which in turn affects the excitability of the neighboring neurons. This interaction occurs through glutamate binding to presynaptic metabotropic glutamate (mGlu) and N-methyl-D-aspartate (NMDA) receptors. Because the source of neurotransmitters inside astrocytes is limited, the kinetic equation for $ f $ contains a saturation term ($ 1-f $). Therefore, the interaction between astrocytes and neurons can be expressed by the following formula[23,24,25,26,27]:

    $ dfdt=fτCa2++(1f)kϕ([Ca2+][Ca2+]th),
    $
    (2.14)
    $ IastSTN=γ1f,
    $
    (2.15)
    $ IastGPe=γ2f,
    $
    (2.16)

    where $ [Ca^{2+}]_{th} $ is the given calcium threshold, $ \phi $ is the Heaviside step function, and $ k $ is the scaling factor. $ I_{STN}^{ast} $ and $ I_{GPe}^{ast} $ denote the currents of the astrocyte acting onto the STN and GPe, respectively, and $ \gamma_1 $ and $ \gamma_2 $ are the functioning intensities of astrocyte. For specific parameter values, please refer to [24].

    In addition, if we consider the effects of astrocytes on the STN and GPe neurons, then Eqs (2.1) and (2.2) will become the following:

    $ CmvSTN=ILINaIKITICaIAHPIGPeSTNIastSTN,
    $
    (2.17)
    $ CmvGPe=ILINaIKITICaIAHPISTNGPeIGPeGPeIastGPe+Iapp.
    $
    (2.18)

    All simulations are written and performed under the MATLAB environment (The Mathworks, Natick, MA, USA). Ordinary differential equations in our system are integrated using the standard forward Euler method with a fixed temporal resolution of 0.01 ms. The total duration of the numerical simulation is set to $ 5*10^4 $ ms.

    Using the sparsely connected circuit described in [19], we can produce a variety of firing patterns as shown in Figure 1. Each STN sends an excitatory input to its nearest GPe neuron, while each GPe neuron sends an inhibitory input to the two directly adjacent GPe neurons and two STN neurons that skip the three nearest located STN neurons.

    Figure 1.  Schematic diagram of sparsely connected circuit of 10 STN neurons and 10 GPe neurons. Each STN sends excitatory input to its nearest GPe neuron, while each GPe neuron has inhibitory connections to the two directly adjacent GPe neurons and two STN neurons that skip the three nearest located neurons. The blue lines represent inhibitory connections and the red lines represent excitatory connections.

    When the inhibitory effect of the GPe neurons is large, the STN may produce a rebound burst firing behavior. The stronger the inhibitory effect, the more obvious the rebound burst discharge of the STN, thus indicating that the pathological oscillation of PD is more serious. By changing the synaptic connection parameters between the STN and the GPe, we reproduce the five typical asynchronous discharge patterns in Figure 2.

    Figure 2.  The activity patterns of STN neuron in the sparsely connected network. Five distinct firing patterns can be obtained by changing the values of synaptic parameters. (a) $ g_{STN\rightarrow GPe} = 0.2\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 2.25\; nS/\mu m^2 $. (b) $ g_{STN\rightarrow GPe} = 0.6\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 2.25\; nS/\mu m^2 $. (c) $ g_{STN\rightarrow GPe} = 0.9\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 2.25\; nS/\mu m^2 $. (d) $ g_{STN\rightarrow GPe} = 0.9\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 2.5\; nS/\mu m^2 $. (e) $ g_{STN\rightarrow GPe} = 0.9\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 4.5\; nS/\mu m^2 $. (f) $ g_{STN\rightarrow GPe} = 0.9\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 4.5\; nS/\mu m^2 $, select a set of initial values to make continous wave have significant inter-group/intra-group synchronization.

    Here, we set the striatum input current $ I_{app} = -1\; pA/\mu m^2 $ for the GPe. As shown in Figure 2(a), when $ g_{STN\rightarrow GPe} = 0.2\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 2.25\; nS/\mu m^2 $, the STN exhibits a regular physiological sparse firing, which is defined as a weak cluster. After strengthening the synaptic connection of the STN to the GPe, i.e., $ g_{STN\rightarrow GPe} = 0.6\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 2.25\; nS/\mu m^2 $ (see Figure 2(b)), the excitation of the GPe leads to an increased inhibition of STN, such that some random burst firings appear in the STN, and this discharge pattern is named as an episodic cluster. When $ g_{STN\rightarrow GPe} $ to $ 0.9\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 2.25\; nS/\mu m^2 $ (see Figure 2(c)) continuously increases, the discharge mode of the STN changes to a continuous cluster. Then, we fix $ g_{STN\rightarrow GPe} = 0.9\; nS/\mu m^2 $. In Figure 2(d), when $ g_{GPe\rightarrow STN} = 2.5\; nS/\mu m^2 $, the STN shows a continuous burst discharge behavior, which is defined as episodic. With $ g_{GPe\rightarrow STN} = 4.5\; nS/\mu m^2 $, the STN's rebound burst lasts longer and we define it as a continuous wave. Considering that excessive beta-band oscillations (13–30 Hz) and a high synchronization between the STN neuron firing are closely related to the severity of PD symptoms, we select two groups of different initial values to obtain a continous wave discharge pattern and take it as the initial pathological state in the simulation below. As shown in Figure 2(f), we can capture the obvious in-phase and anti-phase firings between the two groups.

    It is worth noting that five discharge modes are generated in the sparsely connected network, in which a weak cluster, an episodic cluster, and a continuous cluster indicate healthy physiological states. In contrast, episodic and continuous waves indicate pathological oscillations of the PD state.

    Then, we further consider the role of astrocytes on the sparsely connected STN-GPe network, as shown in Figure 3. For simplicity, this subsection assumes that astrocytes have the same regulatory effect on the STN and the GPe (i.e., $ \gamma_1 = \gamma_2 = \gamma $). When $ \gamma $ takes a negative value, it means that the astrocytes have an inhibitory effect on the STN and an excitatory effect on the GPe. Note that the minus sign here is only to indicate the ultimate excitatory/inhibitory effect of the astrocytes on the neurons, and does not indicate the magnitude of the coupling strength $ \gamma $. The initial pathological selection of continuous waves with an obvious synchronicity as shown in Figure 2(f), and at t = 0.5 * 10$ ^4 $ ms, we change the value of $ \gamma $ from 0 to -2.3, -4, -6, and -7, respectively. As seen in Figure 4, we can clearly see the waveform transitions after the astrocytes act on neurons. When changing the coupling strength from -2.3 to -7, weak clusters, episodic clusters, continuous clusters, and episodic can all arise under appropriate conditions, and become out of synchronization. Specifically, in Figure 4(a), when $ \gamma $ is -2.3, the astrocytes gradually modulate pathological wave discharge and arise sporadic sparse firing, breaking the synchronous discharge of the STN. When $ \gamma $ increases to -4 (see Figure 4(b)), the corresponding firing alternately transforms into weak cluster and episdic cluster alternately. By increasing coupling strength to -6 (see Figure 4(c)), the discharge mode of the STN is nearly in weak cluster. As displayed in Figure 4(d)), with a larger coupling strength of -7, the STN are suppressed, resulting in sparse firing. Figure 4 demonstrates that the astrocytes acting on neurons can modulate the pathological firing pattern of the STN.

    Figure 3.  Schematic diagram of sparsely connected circuit of STN-GPe-AS (astrocytes). The connection between STN-GPe is the same as that shown in Figure 1. Each astrocyte acts on the adjacent STN and GPe. The blue lines represent inhibitory connections and the red lines represent excitatory connections. Solid and dotted lines in green indicate the effects of astrocytes on STN and GPe respectively.
    Figure 4.  The response of STN population under different coupling strength $ \gamma $. (a) $ \gamma = -2.3 $. (b) $ \gamma = -4 $. (c) $ \gamma = -6 $. (d) $ \gamma = -7 $. Note that the minus sign here is only to indicate the ultimate excitatory/inhibitory effect of the astrocytes on the neurons, and does not indicate the magnitude of the coupling strength $ \gamma $ (similarly hereinafter). The initial pathological selection of continuous waves with obvious synchronicity as shown in Figure 2(f). Under appropriate coupling strength $ \gamma $, weak clusters, episodic clusters, continuous clusters, episodic and continuous waves can originate, and remain out of synchronous all the time.

    To more systematically investigate the effect of the coupling strength $ \gamma $, we vary the value of $ \gamma $ from -7 to 0. Based on the above phenomenon, we provide the firing state transition diagram of the STN, as shown in Figure 5(a). Due to the very rapid and transient nature of STN evolution, achieving precise firing state distinctions based on time series is challenging. Consequently, while our method of determining the discharge patterns shown here is not definitive, it can still provide meaningful insights into the role of astrocytes. From the perspective of temporal evolution, when the $ \gamma $ value exceeds -2.5, the firing state of the STN neurons is more likely to transition from a pathological mode to a more sparse episodic cluster firing pattern. In addition, [28,29,30] used the variance of neuronal voltage to define the degree of desynchronization and thus quantitatively measured the synchrony between neurons. When the voltage activity of neurons is synchronized, their voltage waveforms have similar shapes and frequencies, resulting in a lower variance of the neuronal voltage. On the contrary, when the voltage activity of neurons is asynchronous, their voltage waveforms greatly differ, resulting in a higher variance of neuronal voltage. Therefore, using the variance of neuronal voltage to represent the desynchronization degree is an intuitive and effective method, which can help us quantify the degree of synchronization of neuronal networks. The specific formula is as follows:

    $ σ=1TTj=1σ(j),
    $
    (3.1)
    $ σ(j)=1NNi=1[V(j)i]21N(Ni=1[V(j)i])2,
    $
    (3.2)

    where i and j represent the indexes of neurons and time steps, respectively. In total, there are 10 STN neurons (N = 10) and the total numerical simulation time is $ 5*10^4 $ ms. When the desynchronization index is larger, it means that the synchronization of the system is lower.

    Figure 5.  (a) Firing state transitions diagram. (b1, b2) The relationship between the two dynamical measures (i.e., desynchronization degree and the beta band power) and $ \gamma $. (c, d) STN population patterns under coupling strength $ \gamma = -2.5 $ and $ \gamma = -2 $ respectively. (e1, e2) STN's synchronization degree $ S $ in case of (c, d).

    As the coupling strength $ \gamma $ increases, that is, when the inhibitory effect of astrocytes on the STN and the excitatory effect on the GPe increase, we can see that the desynchronization index of the STN becomes larger and larger (shown in Figure 5(b1)), which means that the synchronized oscillations between the STN neurons become weaker and weaker; at the same time, the beta oscillation power of the STN neurons gradually recede (shown in Figure 5(b2)). Figure 5(c) shows the situation when $ \gamma $ is set to -2.5, the discharge mode of the STN transitions from pathological oscillation to continuous firing. At the same time, the synchronization level among the 10 STN neurons also significantly decreases, as illustrated in Figure 5(e1), where the equal-time correlation matrix is used to measure the synchronization level:

    $ Cij(tc)=1NnT(tc)[˜Xi(tn)˜Xj(tn)],
    $
    (3.3)
    $ ˜Xi(tn)=Xi(tn)¯Xi(tn)σi,
    $
    (3.4)
    $ S=MM1[λMMi=1λi1M].
    $
    (3.5)

    The detailed explanations of all parameters can be found in [31]. Specifically, S = 1 means that all the STN neurons are completely synchronized, whereas S = 0 indicates that all STN neurons are completely out of synchronization. In addition, it should be noted that when the value of $ \gamma $ is small, for example, equal to -2, as shown in the Figure 5(d), the discharge pattern of the STN neurons has almost no change and is still in a continuous cluster discharge state. Figure 5(e2) shows the corresponding synchronicity change over time, in which the synchrony level is generally high. The discharge mode and synchronization of the STN do not change obviously, so we still consider it to be pathological at this case.

    Furthermore, we consider the situation when $ \gamma $ takes a positive value, which corresponds to the excitatory effect of astrocytes on the STN and inhibitory effect on the GPe. In fact, in this case, no matter how $ \gamma $ changes, the initial pathological discharge state of the STN will not change significantly. As shown in Figure 6, $ \gamma = 5 $ is used as an example for a schematic explanation.

    Figure 6.  STN population patterns under sparsely connected when coupling strength $ \gamma = 5 $. It is still discharging in a continuous wave.

    Finally, as displayed in Figure 7, we comprehensively consider the situation $ \gamma_1 \neq \gamma_2 $. Overall, when $ \gamma_2 $ is fixed and $ \gamma_1 $ varies, there is little difference in the synchrony between neurons and the power of beta oscillations. As $ \gamma_2 $ gradually changes from -1 to -7, no matter how $ \gamma_1 $ changes, the overall desynchronization index becomes larger, that is, the synchronization of neurons weakens, and at the same time, the power of beta oscillation also gradually decreases. This indicates that $ \gamma_2 $ plays a dominant role in regulating neuronal firing patterns, changing synchrony, and in beta oscillations. Figure 7(c), (d) show two special cases, respectively.

    Figure 7.  Degree of desynchronization (a) and beta band power (b) under different coupling strength $ \gamma_1 $ and $ \gamma_2 $. $ \gamma_2 $ plays a dominant role in regulating neuronal firing patterns, changing synchrony and beta oscillations. (c) $ \gamma_1 = -6 $, $ \gamma_2 = -1 $, the firing pattern do not have obvious change. (d) $ \gamma_1 = -1 $, $ \gamma_2 = -6 $, the pathological oscillation is weakend and even eliminated. Here, we add the effect of astrocytes at $ t = 0.5*10^4 $ ms.

    As described in [19], episodic and waves are the most common pathological patterns in sparsely connected neural networks. In order to obtain a more relevant rhythm, according to [19], we further consider the tightly connected coupling mode shown in Figure 8.

    Figure 8.  Schematic diagram of tightly connected circuit of 10 STN neurons and 10 GPe neurons. Each STN neuron sends excitatory input to the three closest GPe. Each GPe not only inhibits six other GPe neurons adjacent to it, but also has inhibitory connections with five STN neurons that are next to it. The blue lines represent inhibitory connections and the red lines represent excitatory connections.

    Similarly, we obtain five different firing patterns at different levels of synaptic strength, as Figure 9 illustrates. Fixing $ g_{GPe \rightarrow GPe} = 0.01 $ and $ g_{STN \rightarrow GPe} = 2 $, we can obtain some discrete and irregular firings. When $ g_{GPe \rightarrow STN} = 2.25 $, there will be a sparse firing, as seen in Figure 9(a); decreasing $ g_{GPe \rightarrow STN} $ to 1 results in weak cluster, as shown in Figure 9(b). Compared to weak cluster, if lifting $ g_{GPe \rightarrow GPe} $ to 0.06, then a continuous cluster will show up, as shown in Figure 9(c). Keeping $ g_{GPe \rightarrow GPe} = \; 0.06 $, when $ g_{STN \rightarrow GPe} = 0.8 $ and $ g_{GPe \rightarrow STN} = 3.6 $, continuous wave will be produced, as seen in Figure 9(d). Strengthening $ g_{STN \rightarrow GPe} = 1.3 $, there will appear continuous firing pattern, as seen Figure 9(e). In the tightly connected network, continuous cluster, continuous wave, and continuous firing all exhibit obvious and highly in-phase and anti-phase discharge patterns. It is worth noting that these three firing patterns are generally regarded as abnormal activities highly correlated with PD.

    Figure 9.  The activity patterns of STN neuron in the tightly connected network. Five distinct firing patterns can be obtained by varying the values of synaptic model parameters. (a) $ g_{GPe\rightarrow GPe} = 0.01\; nS/\mu m^2 $, $ g_{STN\rightarrow GPe} = 2\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 2.25\; nS/\mu m^2 $. (b) $ g_{GPe\rightarrow GPe} = 0.01\; nS/\mu m^2 $, $ g_{STN\rightarrow GPe} = 2\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 1\; nS/\mu m^2 $. (c) $ g_{GPe\rightarrow GPe} = 0.06\; nS/\mu m^2 $, $ g_{STN\rightarrow GPe} = 2\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 1\; nS/\mu m^2 $. (d) $ g_{GPe\rightarrow GPe} = 0.06\; nS/\mu m^2 $, $ g_{STN\rightarrow GPe} = 0.8\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 3.6\; nS/\mu m^2 $. (e) $ g_{GPe\rightarrow GPe} = 0.06\; nS/\mu m^2 $, $ g_{STN\rightarrow GPe} = 1.3\; nS/\mu m^2 $, $ g_{GPe\rightarrow STN} = 3.6\; nS/\mu m^2 $.

    In the context of tight connections, we also consider the influence of astrocytes on the firing pattern of the network, where a schematic diagram of the connections is shown in the Figure 10.

    Figure 10.  Schematic diagram of tightly connected circuit of STN-GPe-AS (astrocytes). The connection between STN-GPe is the same as that shown in Figure 8. Each astrocyte acts on the adjacent STN and GPe. The blue lines represent inhibitory connections and the red lines represent excitatory connections. Solid and dotted lines in green indicate the effects of astrocytes on STN and GPe respectively.

    First, continuous waves are used as a background state to explore the role of astrocytes. As shown in Figure 11, when the coupling strength is varied, the firing pattern of the STN and the synchronization between neurons change correspondingly. Under a proper coupling strength, astrocytes can transfer continuous waves of background state to the other four discharge modes, holding the characteristic of non-synchronization. Furthermore, we set the value of $ \gamma $ from -0.7 to -2.5 (seen Figure 12), and find that the synchronization is greatly reduced within this parameter range, while the power of beta band does not drop below the level of the initial pathological state until about -1.2. Therefore, in summary, when $ \gamma \in (-2.5, -1.2) $, astrocytes can achieve effective regulatory effects.

    Figure 11.  The response of STN population under different coupling strength $ \gamma $. (a) $ \gamma = -1.3 $. (b) $ \gamma = -1.9 $. (c) $ \gamma = -2.5 $. The initial pathological selection of continuous waves with obvious synchronicity as shown in Figure 9(d). Under appropriate coupling strength, the continuous waves that represent the pathology can be broken or even eliminated, and the neurons will always remain out of sync in the process.
    Figure 12.  The relationship between the two dynamical measures (i.e., desynchronization degree (a) and the beta band power (b)) and $ \gamma $. The red dotted line indicates the baseline value corresponding to the initial pathological state. When $ \gamma \in(-2.5, -1.2) $, desynchronization degree stays in a high level, meaning that the synchronization is greatly reduced, and the beta oscillation is also weakend.

    Similar to the situation of sparse connections, when $ \gamma $ takes a positive value, that is, astrocytes have an excitatory effect on the STN and an inhibitory effect on the GPe, no matter how $ \gamma $ changes, astrocytes have no significant regulatory effect on pathological discharge patterns. Figure 13 takes $ \gamma = 2.5 $ as an example to illustrate.

    Figure 13.  STN population patterns under tightly connected when coupling strength $ \gamma = 2.5 $. The initial pathological discharge state of the STN do not change, and still keep high synchronization.

    Finally, we consider the case where $ \gamma_1 \neq \gamma_2 $. As shown in Figure 14, when $ \gamma_2 $ is fixed, it can be seen that the synchronization and beta oscillation power do not significantly change as $ \gamma_1 $ changes. On the contrary, when $ \gamma_1 $ is fixed, these two indicators will change obviously with the change of $ \gamma_2 $, and the larger the $ \gamma_2 $, the greater the desynchronization index, that is, a decrease of synchronization, accompanied by a decrease of beta oscillation power. These results still indicate that $ \gamma_2 $ plays a leading role in the regulation of PD. This may be due to the fact that the STN is mainly subject to the inhibitory projection of the GPe, and the inhibitory effect of the GPe on the STN is weakened in PD state. Therefore, when the excitatory effect of astrocytes on the GPe is greater, the inhibitory projection of the GPe on the STN can be restored, thus regulating PD state. In addition, the results also showed that the connection mode of the STN-GPe circuit does not affect the regulation effect of astrocytes on PD.

    Figure 14.  Degree of desynchronization (a) and beta band power (b) under different coupling strength $ \gamma_1 $ and $ \gamma_2 $. The red dotted line indicates the baseline value corresponding to the initial pathological state. $ \gamma_2 $ plays a dominant role in regulating neuronal firing patterns, changing synchrony and beta oscillations.

    This work focused on the simulation and analysis of astrocytes on the basal ganglia network. We utilized the STN-GPe model because of its straightforward architecture that represents its crucial pacemaker role in basal ganglia [19,29], which is highly related to the generation of PD-related firing patterns.

    To begin with, we first took the sparsely connected circuit to reproduce five typical firing modes that corresponded to the severity of PD symptoms. Our study theoretically showed how astrocytes regulate neuronal excitability and thus alter their firing patterns. Specifically, the results indicated that when astrocytes inhibit the STN and excite the GPe ($ \gamma \in (-2.3, -7) $), they could achieve transitions between different basic waveforms of the STN, and had certain effects on the synchrony and beta oscillations, which meant an improvement of PD pathology. Especially when $ \gamma $ was greater than -5, the beta oscillation was reduced by about 70%. At the same time, the coupling strength between astrocytes and the GPe played a dominant role in the transition process. Similar results are found in the case of tight connections. Under an appropriate coupling strength ($ \gamma \in (-1.3, -2.5) $), abnormal discharge modes could be destroyed, suppressed, or even eliminated, which includes the transition between different discharge patterns, the destruction of high synchronization among neurons, and the attenuation of excessive beta oscillations. It shows that the results we obtained were robust to a certain extent. The mechanism by which astrocytes exert their effect may be the compensatory effect of dopamine loss, that is, astrocytes compensate for the action of the missing dopamine transmitter to a certain extent, thus affecting the STN-GPe circuit. All these results suggest that astrocytes may be a promising new therapeutic target for PD.

    However, this study simplified the modeling process, making it easier to process and analyze, but at the same time inevitably had some assumptions and limitations. The first is the simplification of network size, where the limited number of neurons in the model might not have been enough to fully capture the complexity of large neural networks, especially when it came to multi-regional interactions. Additionally, the model only considered the STN and the GPe, and ignored neurons in other basal ganglia structures, such as the Globus pallidus internus (GPi) and substantia nigra dopaminergic neurons, which also play a key role in PD. Second, this work was only a preliminary exploration of the effect of the connections between astrocytes and neurons on PD; therefore, it did not consider the connections between astrocytes. In addition, the modeling of astrocytes was simplified and only the key features of astrocyte calcium oscillation were considered. Therefore, in order to more accurately simulate the complex dynamics of the brain in future modeling studies, more refined models are needed, including more cell types, more detailed synaptic dynamics, and more precise anatomical connectivity.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    This research was supported by the National Natural Science Foundation of China (Nos. 12072265, 12372064).

    The authors declare there is no conflict of interest.

    [1]  Finley A, Copeland RA (2014) Small molecule control of chromatin remodeling. Chem Biol 21: 1196–1210. doi: 10.1016/j.chembiol.2014.07.024
    [2]  Prinjha R, Tarakhovsky A (2013) Chromatin targeting drugs in cancer and immunity. Genes Dev 27: 1731–1738. doi: 10.1101/gad.221895.113
    [3]  Rabbani A, Finn RM, Ausio J (2005) The anthracycline antibiotics: antitumor drugs that alter chromatin structure. Bioessays 27: 50–56. doi: 10.1002/bies.20160
    [4]  Majumder P, Pradhan SK, Devi PG, et al. (2007) Chromatin as a target for the DNA-binding anticancer drugs. Subcell Biochem 41: 145–189. doi: 10.1007/1-4020-5466-1_8
    [5]  Banerjee A, Majumder P, Sanyal S, et al. (2014) The DNA intercalators ethidium bromide and propidium iodide also bind to core histones. FEBS Open Bio 4: 251–259. doi: 10.1016/j.fob.2014.02.006
    [6]  Hajihassan Z, Rabbani-Chadegani A (2009) Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins. J Biomed Sci 16: 31. doi: 10.1186/1423-0127-16-31
    [7]  Rabbani-Chadegani A, Chamani E, Hajihassan Z (2009) The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution. Eur J Pharmacol 613: 34–38. doi: 10.1016/j.ejphar.2009.04.040
    [8]  Rabbani-Chadegani A, Keyvani-Ghamsari S, Zarkar N (2011) Spectroscopic studies of dactinomycin and vinorelbine binding to deoxyribonucleic acid and chromatin. Spectrochim Acta A Mol Biomol Spectrosc 84: 62–67. doi: 10.1016/j.saa.2011.08.064
    [9]  Rabbani A, Iskandar M, Ausio J (1999) Daunomycin-induced unfolding and aggregation of chromatin. J Biol Chem 274: 18401–18406. doi: 10.1074/jbc.274.26.18401
    [10]  Mir MA, Majee S, Das S, et al. (2003) Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3. Bioorg Med Chem 11: 2791–2801. doi: 10.1016/S0968-0896(03)00211-6
    [11]  Mir MA, Dasgupta D (2001) Association of the anticancer antibiotic chromomycin A(3) with the nucleosome: role of core histone tail domains in the binding process. Biochemistry 40: 11578–11585. doi: 10.1021/bi010731r
    [12]  Mir MA, Dasgupta D (2001) Interaction of antitumor drug, mithramycin, with chromatin. Biochem Biophys Res Commun 280: 68–74. doi: 10.1006/bbrc.2000.4075
    [13]  Hagmar P, Pierrou S, Nielsen P, et al. (1992) Ionic strength dependence of the binding of methylene blue to chromatin and calf thymus DNA. J Biomol Struct Dyn 9: 667–679. doi: 10.1080/07391102.1992.10507947
    [14]  Mir MA, Das S, Dasgupta D (2004) N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. Biophys Chem 109: 121–135. doi: 10.1016/j.bpc.2003.10.023
    [15]  Hurley LH (2002) DNA and its associated processes as targets forcancer therapy. Nat Rev Cancer 2: 188–200. doi: 10.1038/nrc749
    [16]  Veselkov AN, Davies DB (2002) Anticancer drug design, Sevastopol: Sevntu press, 259.
    [17]  Veselkov AN, Maleev VYa, Glibin EN, et al. (2003) Structure–activity relation for synthetic phenoxazone drugs.Evidence for a direct correlation between DNA binding and pro-apoptotic activity. Eur J Biochem 270: 4200–4207
    [18]  Andersson J, Lincoln P (2011) Stereoselectivity for DNA threading intercalation of short binuclear ruthenium complexes. J Phys Chem B 115: 14768–14775. doi: 10.1021/jp2062767
    [19]  Chaurasiya KR, Paramanathan T, McCauley MJ, et al. (2010) Biophysical characterization of DNA binding from single molecule force measurements. Phys Life Rev 7: 299–341.
    [20]  Nordell P, Lincoln P (2005) Mechanism of DNA threading intercalation of binuclear Ru complexes: uni- or bimolecular pathways depending on ligand structure and binding density. J Am Chem Soc 127: 9670–9671. doi: 10.1021/ja0521674
    [21]  Andersson J, Li M, Lincoln P (2010) AT-specific DNA binding of binuclear ruthenium complexes at the border of threading intercalation. Chemistry 16: 11037–11046.
    [22]  Wilhelmsson LM, Lincoln P, Nordґen B (2006) Slow DNA binding. In: Waring M, editor. Sequence-Specific DNA Binding Agents, The Royal Society of Chemistry, Cambridge, 69–95.
    [23]  Palchaudhuri R, Hergenrother PJ (2007) DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr Opin Biotechnol 18: 497–503. doi: 10.1016/j.copbio.2007.09.006
    [24]  Barton TF, Cooney RP, Denny WA (1992) Surface-enhanced Raman spectroscopic study of amsacrine and amsacrine–DNA interactions. J Raman Spectrosc 23: 341–345.
    [25]  Rodger A, Blagbrough IS, Adlam G, et al. (1994) DNA binding of a spermine derivative: Spectroscopic study of anthracene-9-carbonyl-n1-spermine with poly[d(G-C)·(d(G-C))] and poly[d(A-T) · d(A-T)]. Biopolymers 34: 1583–1593. doi: 10.1002/bip.360341203
    [26]  Hackl EV, Galkin VL, Blagoi YP (2004) DNA interaction with biologically active divalent metal ions: binding constants calculation. Int J Biol Macromol 34: 303–308.
    [27]  Evstigneev MP, Mykhina YV, Davies DB (2005) Complexation of daunomycin with a DNA oligomer in the presence of an aromatic vitamin (B2) determined by NMR spectroscopy. Biophys Chem 118: 118–127. doi: 10.1016/j.bpc.2005.08.007
    [28]  Hackl EV, Blagoi YP (2005) The effect of temperature on DNA structural transitions under the action of Cu2+ and Ca2+ ions in aqueous solutions. Biopolymers 77: 315–324. doi: 10.1002/bip.20225
    [29]  Kruglova EB, Gladkovskaia NA, Maleev V (2005) The use of the spectrophotometric analysis for the calculation of the thermodynamic parameters in actinocin derivative-DNA systems. Biofizika 50: 253–264.
    [30]  Evstigneev MP, Baranovskii SF, Rybakova KA, et al. (2006) 1H NMR study of the complexation of the quinolone antibiotic norfloxacin with DNA. Mol Biol (Mosk) 40: 894–899.
    [31]  Evstigneev MP, Rybakova KA, Davies DB (2006) Complexation of norfloxacin with DNA in the presence of caffeine. Biophys Chem 121: 84–95. doi: 10.1016/j.bpc.2005.12.003
    [32]  Williams AK, Dasilva SC, Bhatta A, et al. (2012) Determination of the drug-DNA binding modes using fluorescence-based assays. Anal Biochem 422: 66–73. doi: 10.1016/j.ab.2011.12.041
    [33]  Anupama B, Sunita M, Shiva LD, et al. (2014) Synthesis, spectral characterization, DNA binding studies and antimicrobial activity of Co(II), Ni(II), Zn(II), Fe(III) and VO(IV) complexes with 4-aminoantipyrine Schiff base of ortho-vanillin. J Fluoresc 24: 1067–1076. doi: 10.1007/s10895-014-1386-z
    [34]  Zasedatelev AS, Gurskii GV, Vol'kenshtein MV (1971) Theory of one-dimensional adsorption. I. Adsorption of small molecules on a homopolymer. Molecular biology 5: 194–198.
    [35]  McGhee JD, von Hippel PH (1974) Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. J Mol Biol 86: 469–489. doi: 10.1016/0022-2836(74)90031-X
    [36]  Schellman JA (1974) Cooperative Multisite Binding to DNA. Israel Journal of Chemistry 12: 219–238. doi: 10.1002/ijch.197400021
    [37]  Nechipurenko YD, Gursky GV (1986) Cooperative effects on binding of proteins to DNA. Biophys Chem 24: 195–209. doi: 10.1016/0301-4622(86)85025-6
    [38]  Lando DY, Teif VB (2000) Long-range interactions between ligands bound to a DNA molecule give rise to adsorption with the character of phase transition of the first kind. J Biomol Struct Dyn 17: 903–911. doi: 10.1080/07391102.2000.10506578
    [39]  Teif VB, Rippe K (2010) Statistical-mechanical lattice models for protein-DNA binding in chromatin. J Phys Condens Matter 22: 414105. doi: 10.1088/0953-8984/22/41/414105
    [40]  Breslauer KJ, Freire E, Straume M (1992) Calorimetry: a tool for DNA and ligand-DNA studies. Methods Enzymol 211: 533–567.
    [41]  Doyle ML (1997) Characterization of binding interactions by isothermal titration calorimetry. Curr Opin Biotechnol 8: 31–35. doi: 10.1016/S0958-1669(97)80154-1
    [42]  Jelesarov I, Bosshard HR (1999) Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J Mol Recognit 12: 3–18.
    [43]  Haq I, Chowdhry BZ, Jenkins TC (2001)Calorimetric techniques in the study of high-order DNA-drug interactions. Methods Enzymol 340: 109–149.
    [44]  Thomson JA, Ladbury JE (2004) Isothermal titration calorimetry: a tutorial. In Ladbury JE, Doyle ML, editors. Biocalorimetry 2. Applications of Calorimetry in the Biological Sciences, Chichester: John Wiley & Sons, 35–58.
    [45]  Holdgate GA, Ward WH (2005) Measurements of binding thermodynamics in drug discovery. Drug Discov Today 10: 1543–1550.
    [46]  Freyer MW, Lewis EA (2008) Isothermal titration calorimetry: experimental design, data analysis, and probing macromolecule/ligand binding and kinetic interactions. Methods Cell Biol 84: 79–113. doi: 10.1016/S0091-679X(07)84004-0
    [47]  Bhadra K, Maiti M, Kumar GS (2008) Berberine–DNA complexation: New insights into the cooperative binding and energetic aspects. Biochimica et Biophysica Acta 1780: 1054–1061. doi: 10.1016/j.bbagen.2008.05.005
    [48]  Hossain M, Kumar GS (2009) DNA intercalation of methylene blue and quinacrine: new insights into base and sequence specificity from structural and thermodynamic studies with polynucleotides. Mol Biosyst 5: 1311–1322.
    [49]  Crane-Robinson C, Dragan AI, Read CM (2009) Defining the thermodynamics of protein/DNA complexes and their components using micro-calorimetry. Methods Mol Biol 543: 625–651. doi: 10.1007/978-1-60327-015-1_37
    [50]  Kabir A, Kumar GS (2013) Binding of the biogenic polyamines to deoxyribonucleic acids of varying base composition: base specificity and the associated energetics of the interaction. PLoS One 8: e70510. doi: 10.1371/journal.pone.0070510
    [51]  Kumar S, Spano MN, Arya DP (2014) Shape readout of AT-rich DNA by carbohydrates. Biopolymers 101: 720–732. doi: 10.1002/bip.22448
    [52]  Basu A, Kumar GS (2015) Thermodynamic characterization of proflavine–DNA binding through microcalorimetric studies. J Chem Thermodyn 87: 1–7. doi: 10.1016/j.jct.2015.03.009
    [53]  Basu A, Kumar GS (2015) Studies on the interaction of the food colorant tartrazine with double stranded deoxyribonucleic acid. J Biomol Struct Dyn 10: 1–8.
    [54]  Chaires JB (1997) Possible origin of differences between van't Hoff and calorimetric enthalpy estimates. Biophys Chem 64: 15–23.
    [55]  Chaires JB (2008) Calorimetry and thermodynamics in drug design. Annu Rev Biophys 37: 135–151.
    [56]  Janjua NK, Siddiqa A, Yaqub A, et al. (2009) Spectrophotometric analysis of flavonoid-DNA binding interactions at physiological conditions. Spectrochim Acta A Mol Biomol Spectrosc 74: 1135–1137. doi: 10.1016/j.saa.2009.09.022
    [57]  Temerk YM, Ibrahim MS, Kotb M (2009) Voltammetric and spectroscopic studies on binding of antitumor Morin, Morin-Cu complex and Morin-beta-cyclodextrin with DNA. Spectrochim Acta A Mol Biomol Spectrosc 71: 1830–1836. doi: 10.1016/j.saa.2008.07.001
    [58]  Baranovskii SF, Chernyshev DN, Buchel’nikov AS, et al. (2011) Thermodynamic analysis of complex formation of ethidium bromide with DNA in water solutions. Biophysics 56: 214–219. doi: 10.1134/S0006350911020023
    [59]   Chaires JB (1997) Energetics of drug-DNA interactions. Biopolymers 44: 201–215.
    [60]   Ren J, Jenkins TC, Chaires JB (2000) Energetics of DNA intercalation reactions. Biochemistry 39: 8439–8447. doi: 10.1021/bi000474a
    [61]  Davies DB, Veselkov AN (1996) Structural and thermodynamical analysis of molecular complexation by 1H NMR spectroscopy. Intercalation of ethidium bromide with the isomeric deoxytetranucleoside triphosphates 5’-d(GpCpGpC) and 5’-d(CpGpCpG) in aqueous solution. J Chem Soc Faraday Trans 92: 3545-3557. doi: 10.1039/ft9969203545
    [62]  Kostjukov VV, Pahomov VI, Andrejuk DD, et al. (2007) Investigation of the complexation of the anti-cancer drug novantrone with the hairpin structure of the deoxyheptanucleotide 5′-d(GpCpGpApApGpC). J Mol Struct 843: 78–86. doi: 10.1016/j.molstruc.2006.12.036
    [63]  Wartell RM, Benight AS (1985) Thermal denaturation of DNA molecules: A comparison of theory with experiment. Phys Rep 126: 67–107. doi: 10.1016/0370-1573(85)90060-2
    [64]  Rice SA, Doty P (1957) The Thermal Denaturation of Desoxyribose Nucleic Acid. J Am Chem Soc 79: 3937–3947. doi: 10.1021/ja01572a001
    [65]  Guedin A, Lacroix L, Mergny JL (2010) Thermal melting studies of ligand DNA interactions. Methods Mol Biol 613: 25–35. doi: 10.1007/978-1-60327-418-0_2
    [66]  Goldstein G, Stern KG (1950) Experiments on the sonic, thermal, and enzymic depolymerization of desoxyribosenucleic acid. J Struc Chem 5: 687–708.
    [67]  Thomas R (1954) Recherches sur la d'enaturation des acides desoxyribonucléiques. Biochimica et Biophysica Acta 14: 231–240. doi: 10.1016/0006-3002(54)90163-8
    [68]  Frank-Kamenetskii M (1965) Theory of the helix–coil transition for deoxyribonucleic acids with additional connections between the chains. Vysokomolekulyarnye Soedineniya 7: 354–361.
    [69]  Frank-Kamenetskii M (1968) Consideration of helix-coil transition in homopolymers by the most probable distribution method. Mol Biol 2: 408–419.
    [70]  Stewart CR (1968) Broadening by acridine orange of the thermal transition of DNA. Biopolymers 6: 1737–1743. doi: 10.1002/bip.1968.360061208
    [71]  Lazurkin YS, Frank-Kamenetskii MD, Trifonov EN (1970) Melting of DNA: its study and application as a research method. Biopolymers 9: 1253–1306. doi: 10.1002/bip.1970.360091102
    [72]  Barcelo F, Capo D, Portugal J (2002) Thermodynamic characterization of the multivalent binding of chartreusin to DNA. Nucleic Acids Res 30: 4567–4573. doi: 10.1093/nar/gkf558
    [73]  Zhong W, Yu JS, Liang Y (2003) Chlorobenzylidine-herring sperm DNA interaction: binding mode and thermodynamic studies. Spectrochim Acta A Mol Biomol Spectrosc 59: 1281–1288. doi: 10.1016/S1386-1425(02)00301-3
    [74]  Vardevanyan PO, Antonyan AP, Hambardzumyan LA, et al. (2013) Thermodynamic analysis of DNA complexes with methylene blue, ethidium bromide and Hoechst 33258. Biopolym. Cell 29: 515–520. doi: 10.7124/bc.000843
    [75]  Hajian R, Guan Huat T (2013) Spectrophotometric Studies on the Thermodynamics of the ds-DNA Interaction with Irinotecan for a Better Understanding of Anticancer Drug-DNA Interactions. J Spectrosc 2013: 1–8.
    [76]  Cooper A, Johnson CM (1994) Introduction to microcalorimetry and biomolecular energetics. Methods Mol Biol 22: 109–24.
    [77]  Rosgen J, Hinz HJ (1999) Theory and practice of DSC mesuarements on proteins. In: Kemp RB, editor. Handbook of Thermal Analysis and Calorimetry, Vol.4, From Macromolecules to Man, Amsterdam: Elsevier, 63–108.
    [78]  Bruylants G, Wouters J, Michaux C (2005) Differential scanning calorimetry in life science: thermodynamics, stability, molecular recognition and application in drug design. Curr Med Chem 12: 2011–2020. doi: 10.2174/0929867054546564
    [79]  Spink CH (2008) Differential scanning calorimetry. Methods Cell Biol 84: 115–141. doi: 10.1016/S0091-679X(07)84005-2
    [80]  Bereznyak EG, Gladkovskaya NA, Khrebtova AS, et al. (2009) Peculiarities of DNA-proflavine binding under different concentration ratios. Biophysics 54: 574–580. doi: 10.1134/S0006350909050030
    [81]  Garbett N (2011) The Use of Calorimetry to Study Ligand–DNA Interactions. In: Aldrich-Wright J, editor. Metallointercalators, Vienna: Springer, 299–324.
    [82]  Ising E (1925) Beitrag zur Theorie des Ferromagnetismus. Zeitschrift für Physik 31: 253–258. doi: 10.1007/BF02980577
    [83]  Poland DC, Scheraga HA (1970) The theory of helix coil transition, New York: Academic Press.
    [84]  Peyrard M, Bishop AR (1989) Statistical mechanics of a nonlinear model for DNA denaturation. Phys Rev Lett 62: 2755–2758. doi: 10.1103/PhysRevLett.62.2755
    [85]  Dauxois T, Peyrard M, Bishop AR (1993) Entropy-driven DNA denaturation. Physical Review E 47: R44–R47. doi: 10.1103/PhysRevE.47.R44
    [86]  Dauxois T, Peyrard M, Bishop AR (1993) Dynamics and thermodynamics of a nonlinear model for DNA denaturation. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 47: 684–695.
    [87]  Grosberg AIU, Khokhlov AR (1994) Statistical physics of macromolecules, New York: AIP Press.
    [88]  Frank-Kamenetskii MD, Prakash S (2014) Fluctuations in the DNA double helix: A critical review. Phys Life Rev 11: 153–170. doi: 10.1016/j.plrev.2014.01.005
    [89]  Cantor CR, Schimmel PR (1980) Biophysical chemistry. 3. The behavior of biological macromolecules, San Francisco, Freeman.
    [90]  Zimm BH, Bragg JK (1959) Theory of the Phase Transition between Helix and Random Coil in Polypeptide Chains. J Chem Phys 31: 526–535. doi: 10.1063/1.1730390
    [91]  Crothers DM (1971) Statistical thermodynamics of nucleic acid melting transitions with coupled binding equilibria. Biopolymers 10: 2147–2160. doi: 10.1002/bip.360101110
    [92]  McGhee JD (1976) Theoretical calculations of the helix-coil transition of DNA in the presence of large, cooperatively binding ligands. Biopolymers 15: 1345–1375. doi: 10.1002/bip.1976.360150710
    [93]   Akhrem AA, Fridman AS, Lando D (1985) Theory of helix-coil transition of the heterogeneous DNA-heteroqeneous ligands complexes. Biopolym Cell 1: 171–179. doi: 10.7124/bc.00017E
    [94]  Lando D (1994) A theoretical consideration of the influence of selective binding of small ligands on DNA helix-coil transition. J Biomol Struct Dyn 12: 343–354. doi: 10.1080/07391102.1994.10508744
    [95]   Akhrem AA, Lando D (1979) Influence of ligands characteristic of selective binding to a certain type of base pairs on DNA helix-coil transition I. Model. Theory. Mol Biol (Mosk) 13: 1098–1109.
    [96]  Akhrem AA, Lando D, Shpakovskii AG, et al. (1990) The effect of long-range interactions between adsorbed ligands on the DNA helix-coil transition. Mol Biol (Mosk) 24: 649–656.
    [97]  Lando D, Ivanova MA, Akhrem AA (1980) Effect of changes in the stoichiometry of DNA-ligand complexes during heat denaturation of DNA on helix-coil transition parameters. Mol Biol (Mosk) 14: 1281–1288.
    [98]  Karapetian AT, Mehrabian NM, Terzikian GA, et al. (1996) Theoretical treatment of melting of complexes of DNA with ligands having several types of binding sites on helical and single-stranded DNA. J Biomol Struct Dyn 14: 275–283. doi: 10.1080/07391102.1996.10508118
    [99]  Plum GE, Bloomfield VA (1990) Structural and electrostatic effects on binding of trivalent cations to double-stranded and single-stranded poly[d (AT)]. Biopolymers 29: 13–27. doi: 10.1002/bip.360290105
    [100]   Spink CH, Chaires JB (1997) Thermodynamics of the Binding of a Cationic Lipid to DNA. J Am Chem Soc 119: 10920–10928. doi: 10.1021/ja964324s
    [101]   Leng F, Chaires JB, Waring MJ (2003) Energetics of echinomycin binding to DNA. Nucleic Acids Res 31: 6191–6197. doi: 10.1093/nar/gkg826
    [102]   Pasic L, Sepcic K, Turk T, et al. (2001) Characterization of parazoanthoxanthin A binding to a series of natural and synthetic host DNA duplexes. Arch Biochem Biophys 393: 132–142. doi: 10.1006/abbi.2001.2469
    [103]   Portugal J, Cashman DJ, Trent JO, et al. (2005) A new bisintercalating anthracycline with picomolar DNA binding affinity. J Med Chem 48: 8209–8219. doi: 10.1021/jm050902g
    [104]   Liu Y-J, Wei X, Mei W-J, et al. (2007) Synthesis, characterization and DNA binding studies of ruthenium(II) complexes: [Ru(bpy)2(dtmi)]2+ and [Ru(bpy)2(dtni)]2+. Transit Metal Chem 32: 762–768. doi: 10.1007/s11243-007-0246-y
    [105]   Peng B, Chen X, Du KJ, et al. (2009) Synthesis, characterization and DNA-binding studies of ruthenium(II) mixed-ligand complexes containing dipyrido[1,2,5]oxadiazolo[3,4-b]quinoxaline. Spectrochim Acta A Mol Biomol Spectrosc 74: 896–901. doi: 10.1016/j.saa.2009.08.031
    [106]   Barcelo F, Portugal J (2004) Elsamicin A binding to DNA. A comparative thermodynamic characterization. FEBS Lett 576: 68–72.
    [107]   Barcelo F, Scotta C, Ortiz-Lombardia M, et al. (2007) Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences. Nucleic Acids Res 35: 2215–2226. doi: 10.1093/nar/gkm037
    [108]   Marky LA, Blumenfeld KS, Breslauer KJ (1983) Calorimetric and spectroscopic investigation of drug-DNA interactions. I. The binding of netropsin to poly d(AT). Nucleic Acids Res 11: 2857–2870.
    [109]   Remeta DP, Mudd CP, Berger RL, et al (1993) Thermodynamic characterization of daunomycin-DNA interactions: comparison of complete binding profiles for a series of DNA host duplexes. Biochemistry 32: 5064–5073. doi: 10.1021/bi00070a014
    [110]   Brandts JF, Lin LN (1990) Study of strong to ultratight protein interactions using differential scanning calorimetry. Biochemistry 29: 69276940.
    [111]   Barone G, Catanzano F, Del Vecchio P, et al. (1995) Differential scanning calorimetry as a tool to study protein-ligand interactions. Pure Appl Chem 67: 1867–1872.
    [112]   Dassie SA, Celej MS, Fidelio GD (2005) Protein Unfolding Coupled to Ligand Binding: Differential Scanning Calorimetry Simulation Approach. J Chem Educ 82: 85. doi: 10.1021/ed082p85
    [113]   Celej MS, Dassie SA, Gonzalez M, et al. (2006) Differential scanning calorimetry as a tool to estimate binding parameters in multiligand binding proteins. Anal Biochem 350: 277–284. doi: 10.1016/j.ab.2005.12.029
    [114]   Esposito D, Del Vecchio P, Barone G (2001) A thermodynamic study of herring protamine-DNA complex by differential scanning calorimetry. Phys Chem Chem Phys 3: 5320–5325. doi: 10.1039/b107218h
    [115]   Dukhopelnikov EV, Bereznyak EG, Khrebtova AS, et al. (2013) Determination of ligand to DNA binding parameters from two-dimensional DSC curves. J Therm Anal Calorim 111: 1817–1827. doi: 10.1007/s10973-012-2561-6
    [116]   Straume M, Freire E (1992) Two-dimensional differential scanning calorimetry: Simultaneous resolution of intrinsic protein structural energetics and ligand binding interactions by global linkage analysis. Anal Biochem 203: 259–268. doi: 10.1016/0003-2697(92)90311-T
    [117]   Freire E (1994) Statistical thermodynamic analysis of differential scanning calorimetry data: structural deconvolution of heat capacity function of proteins. Methods Enzymol 240: 502–530. doi: 10.1016/S0076-6879(94)40062-8
    [118]   Freire E (1995) Differential scanning calorimetry. Methods Mol Biol 40: 191–218.
    [119]   Marky LA, Breslauer KJ (1987) Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves. Biopolymers 26: 1601–1620. doi: 10.1002/bip.360260911
    [120]   Sturtevant JM (1987) Biochemical Applications of Differential Scanning Calorimetry. Annu Rev Phys Chem 38: 463–488. doi: 10.1146/annurev.pc.38.100187.002335
    [121]   Kawai Y (1999) Thermal transition profiles of bacteriophage T4 and its DNA. J Gen Appl Microbiol 45: 135–138. doi: 10.2323/jgam.45.135
    [122]   Tostesen E, Sandve GK, Liu F, et al. (2009) Segmentation of DNA sequences into twostate regions and melting fork regions. J Phys Condens Matter 21: 034109. doi: 10.1088/0953-8984/21/3/034109
    [123]   Duguid JG, Bloomfield VA, Benevides JM, et al. (1996) DNA melting investigated by differential scanning calorimetry and Raman spectroscopy. Biophys J 71: 3350–3360.
    [124]   Movileanu L, Benevides JM, Thomas GJ (2002) Determination of base and backbone contributions to the thermodynamics of premelting and melting transitions in B DNA. Nucleic Acids Res 30: 3767–3777. doi: 10.1093/nar/gkf471
    [125]   Dukhopelnikov EV (2014) Modeling of heat absorption curves for ligand-competitor-DNA triple system. Biophysical Bulletin 31: 49–58.
    [126] 1. Finley A, Copeland RA (2014) Small molecule control of chromatin remodeling. Chem Biol 21: 1196-1210. doi: 10.1016/j.chembiol.2014.07.024
    [127] 2. Prinjha R, Tarakhovsky A (2013) Chromatin targeting drugs in cancer and immunity. Genes Dev 27: 1731-1738. doi: 10.1101/gad.221895.113
    [128] 3. Rabbani A, Finn RM, Ausio J (2005) The anthracycline antibiotics: antitumor drugs that alter chromatin structure. Bioessays 27: 50-56. doi: 10.1002/bies.20160
    [129] 4. Majumder P, Pradhan SK, Devi PG, et al. (2007) Chromatin as a target for the DNA-binding anticancer drugs. Subcell Biochem 41: 145-189. doi: 10.1007/1-4020-5466-1_8
    [130] 5. Banerjee A, Majumder P, Sanyal S, et al. (2014) The DNA intercalators ethidium bromide and propidium iodide also bind to core histones. FEBS Open Bio 4: 251-259. doi: 10.1016/j.fob.2014.02.006
    [131] 6. Hajihassan Z, Rabbani-Chadegani A (2009) Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins. J Biomed Sci 16: 31. doi: 10.1186/1423-0127-16-31
    [132] 7. Rabbani-Chadegani A, Chamani E, Hajihassan Z (2009) The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution. Eur J Pharmacol 613: 34-38. doi: 10.1016/j.ejphar.2009.04.040
    [133] 8. Rabbani-Chadegani A, Keyvani-Ghamsari S, Zarkar N (2011) Spectroscopic studies of dactinomycin and vinorelbine binding to deoxyribonucleic acid and chromatin. Spectrochim Acta A Mol Biomol Spectrosc 84: 62-67. doi: 10.1016/j.saa.2011.08.064
    [134] 9. Rabbani A, Iskandar M, Ausio J (1999) Daunomycin-induced unfolding and aggregation of chromatin. J Biol Chem 274: 18401-18406. doi: 10.1074/jbc.274.26.18401
    [135] 10. Mir MA, Majee S, Das S, et al. (2003) Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3. Bioorg Med Chem 11: 2791-2801. doi: 10.1016/S0968-0896(03)00211-6
    [136] 11. Mir MA, Dasgupta D (2001) Association of the anticancer antibiotic chromomycin A(3) with the nucleosome: role of core histone tail domains in the binding process. Biochemistry 40: 11578-11585. doi: 10.1021/bi010731r
    [137] 12. Mir MA, Dasgupta D (2001) Interaction of antitumor drug, mithramycin, with chromatin. Biochem Biophys Res Commun 280: 68-74. doi: 10.1006/bbrc.2000.4075
    [138] 13. Hagmar P, Pierrou S, Nielsen P, et al. (1992) Ionic strength dependence of the binding of methylene blue to chromatin and calf thymus DNA. J Biomol Struct Dyn 9: 667-679. doi: 10.1080/07391102.1992.10507947
    [139] 14. Mir MA, Das S, Dasgupta D (2004) N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. Biophys Chem 109: 121-135. doi: 10.1016/j.bpc.2003.10.023
    [140] 15. Hurley LH (2002) DNA and its associated processes as targets forcancer therapy. Nat Rev Cancer 2: 188-200. doi: 10.1038/nrc749
    [141] 17. Veselkov AN, Maleev VYa, Glibin EN, et al. (2003) Structure-activity relation for synthetic phenoxazone drugs.Evidence for a direct correlation between DNA binding and pro-apoptotic activity. Eur J Biochem 270: 4200-4207
    [142] 18. Andersson J, Lincoln P (2011) Stereoselectivity for DNA threading intercalation of short binuclear ruthenium complexes. J Phys Chem B 115: 14768-14775. doi: 10.1021/jp2062767
    [143] 19. Chaurasiya KR, Paramanathan T, McCauley MJ, et al. (2010) Biophysical characterization of DNA binding from single molecule force measurements. Phys Life Rev 7: 299-341.
    [144] 20. Nordell P, Lincoln P (2005) Mechanism of DNA threading intercalation of binuclear Ru complexes: uni- or bimolecular pathways depending on ligand structure and binding density. J Am Chem Soc 127: 9670-9671. doi: 10.1021/ja0521674
    [145] 21. Andersson J, Li M, Lincoln P (2010) AT-specific DNA binding of binuclear ruthenium complexes at the border of threading intercalation. Chemistry 16: 11037-11046.
    [146] 22. Wilhelmsson LM, Lincoln P, Nordґen B (2006) Slow DNA binding. In: Waring M, editor. Sequence-Specific DNA Binding Agents, The Royal Society of Chemistry, Cambridge, 69-95.
    [147] 23. Palchaudhuri R, Hergenrother PJ (2007) DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr Opin Biotechnol 18: 497-503. doi: 10.1016/j.copbio.2007.09.006
    [148] 24. Barton TF, Cooney RP, Denny WA (1992) Surface-enhanced Raman spectroscopic study of amsacrine and amsacrine-DNA interactions. J Raman Spectrosc 23: 341-345.
    [149] 25. Rodger A, Blagbrough IS, Adlam G, et al. (1994) DNA binding of a spermine derivative: Spectroscopic study of anthracene-9-carbonyl-n1-spermine with poly[d(G-C)·(d(G-C))] and poly[d(A-T) · d(A-T)]. Biopolymers 34: 1583-1593. doi: 10.1002/bip.360341203
    [150] 26. Hackl EV, Galkin VL, Blagoi YP (2004) DNA interaction with biologically active divalent metal ions: binding constants calculation. Int J Biol Macromol 34: 303-308.
    [151] 27. Evstigneev MP, Mykhina YV, Davies DB (2005) Complexation of daunomycin with a DNA oligomer in the presence of an aromatic vitamin (B2) determined by NMR spectroscopy. Biophys Chem 118: 118-127. doi: 10.1016/j.bpc.2005.08.007
    [152] 28. Hackl EV, Blagoi YP (2005) The effect of temperature on DNA structural transitions under the action of Cu2+ and Ca2+ ions in aqueous solutions. Biopolymers 77: 315-324. doi: 10.1002/bip.20225
    [153] 29. Kruglova EB, Gladkovskaia NA, Maleev V (2005) The use of the spectrophotometric analysis for the calculation of the thermodynamic parameters in actinocin derivative-DNA systems. Biofizika 50: 253-264.
    [154] 30. Evstigneev MP, Baranovskii SF, Rybakova KA, et al. (2006) 1H NMR study of the complexation of the quinolone antibiotic norfloxacin with DNA. Mol Biol (Mosk) 40: 894-899.
    [155] 31. Evstigneev MP, Rybakova KA, Davies DB (2006) Complexation of norfloxacin with DNA in the presence of caffeine. Biophys Chem 121: 84-95. doi: 10.1016/j.bpc.2005.12.003
    [156] 32. Williams AK, Dasilva SC, Bhatta A, et al. (2012) Determination of the drug-DNA binding modes using fluorescence-based assays. Anal Biochem 422: 66-73. doi: 10.1016/j.ab.2011.12.041
    [157] 33. Anupama B, Sunita M, Shiva LD, et al. (2014) Synthesis, spectral characterization, DNA binding studies and antimicrobial activity of Co(II), Ni(II), Zn(II), Fe(III) and VO(IV) complexes with 4-aminoantipyrine Schiff base of ortho-vanillin. J Fluoresc 24: 1067-1076. doi: 10.1007/s10895-014-1386-z
    [158] 34. Zasedatelev AS, Gurskii GV, Vol'kenshtein MV (1971) Theory of one-dimensional adsorption. I. Adsorption of small molecules on a homopolymer. Molecular biology 5: 194-198.
    [159] 35. McGhee JD, von Hippel PH (1974) Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. J Mol Biol 86: 469-489. doi: 10.1016/0022-2836(74)90031-X
    [160] 36. Schellman JA (1974) Cooperative Multisite Binding to DNA. Israel Journal of Chemistry 12: 219-238. doi: 10.1002/ijch.197400021
    [161] 37. Nechipurenko YD, Gursky GV (1986) Cooperative effects on binding of proteins to DNA. Biophys Chem 24: 195-209. doi: 10.1016/0301-4622(86)85025-6
    [162] 38. Lando DY, Teif VB (2000) Long-range interactions between ligands bound to a DNA molecule give rise to adsorption with the character of phase transition of the first kind. J Biomol Struct Dyn 17: 903-911. doi: 10.1080/07391102.2000.10506578
    [163] 39. Teif VB, Rippe K (2010) Statistical-mechanical lattice models for protein-DNA binding in chromatin. J Phys Condens Matter 22: 414105. doi: 10.1088/0953-8984/22/41/414105
    [164] 40. Breslauer KJ, Freire E, Straume M (1992) Calorimetry: a tool for DNA and ligand-DNA studies. Methods Enzymol 211: 533-567.
    [165] 41. Doyle ML (1997) Characterization of binding interactions by isothermal titration calorimetry. Curr Opin Biotechnol 8: 31-35. doi: 10.1016/S0958-1669(97)80154-1
    [166] 42. Jelesarov I, Bosshard HR (1999) Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J Mol Recognit 12: 3-18. doi: 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6
    [167] 43. Haq I, Chowdhry BZ, Jenkins TC (2001)Calorimetric techniques in the study of high-order DNA-drug interactions. Methods Enzymol 340: 109-149.
    [168] 44. Thomson JA, Ladbury JE (2004) Isothermal titration calorimetry: a tutorial. In Ladbury JE, Doyle ML, editors. Biocalorimetry 2. Applications of Calorimetry in the Biological Sciences, Chichester: John Wiley & Sons, 35-58.
    [169] 45. Holdgate GA, Ward WH (2005) Measurements of binding thermodynamics in drug discovery. Drug Discov Today 10: 1543-1550.
    [170] 46. Freyer MW, Lewis EA (2008) Isothermal titration calorimetry: experimental design, data analysis, and probing macromolecule/ligand binding and kinetic interactions. Methods Cell Biol 84: 79-113. doi: 10.1016/S0091-679X(07)84004-0
    [171] 47. Bhadra K, Maiti M, Kumar GS (2008) Berberine-DNA complexation: New insights into the cooperative binding and energetic aspects. Biochimica et Biophysica Acta 1780: 1054-1061. doi: 10.1016/j.bbagen.2008.05.005
    [172] 48. Hossain M, Kumar GS (2009) DNA intercalation of methylene blue and quinacrine: new insights into base and sequence specificity from structural and thermodynamic studies with polynucleotides. Mol Biosyst 5: 1311-1322.
    [173] 49. Crane-Robinson C, Dragan AI, Read CM (2009) Defining the thermodynamics of protein/DNA complexes and their components using micro-calorimetry. Methods Mol Biol 543: 625-651. doi: 10.1007/978-1-60327-015-1_37
    [174] 50. Kabir A, Kumar GS (2013) Binding of the biogenic polyamines to deoxyribonucleic acids of varying base composition: base specificity and the associated energetics of the interaction. PLoS One 8: e70510. doi: 10.1371/journal.pone.0070510
    [175] 51. Kumar S, Spano MN, Arya DP (2014) Shape readout of AT-rich DNA by carbohydrates. Biopolymers 101: 720-732. doi: 10.1002/bip.22448
    [176] 52. Basu A, Kumar GS (2015) Thermodynamic characterization of proflavine-DNA binding through microcalorimetric studies. J Chem Thermodyn 87: 1-7. doi: 10.1016/j.jct.2015.03.009
    [177] 53. Basu A, Kumar GS (2015) Studies on the interaction of the food colorant tartrazine with double stranded deoxyribonucleic acid. J Biomol Struct Dyn 10: 1-8.
    [178] 54. Chaires JB (1997) Possible origin of differences between van't Hoff and calorimetric enthalpy estimates. Biophys Chem 64: 15-23.
    [179] 55. Chaires JB (2008) Calorimetry and thermodynamics in drug design. Annu Rev Biophys 37: 135-151.
    [180] 56. Janjua NK, Siddiqa A, Yaqub A, et al. (2009) Spectrophotometric analysis of flavonoid-DNA binding interactions at physiological conditions. Spectrochim Acta A Mol Biomol Spectrosc 74: 1135-1137. doi: 10.1016/j.saa.2009.09.022
    [181] 57. Temerk YM, Ibrahim MS, Kotb M (2009) Voltammetric and spectroscopic studies on binding of antitumor Morin, Morin-Cu complex and Morin-beta-cyclodextrin with DNA. Spectrochim Acta A Mol Biomol Spectrosc 71: 1830-1836. doi: 10.1016/j.saa.2008.07.001
    [182] 58. Baranovskii SF, Chernyshev DN, Buchel’nikov AS, et al. (2011) Thermodynamic analysis of complex formation of ethidium bromide with DNA in water solutions. Biophysics 56: 214-219. doi: 10.1134/S0006350911020023
    [183] 59. Chaires JB (1997) Energetics of drug-DNA interactions. Biopolymers 44: 201-215.
    [184] 60. Ren J, Jenkins TC, Chaires JB (2000) Energetics of DNA intercalation reactions. Biochemistry 39: 8439-8447.
    [185] 61. Davies DB, Veselkov AN (1996) Structural and thermodynamical analysis of molecular complexation by 1H NMR spectroscopy. Intercalation of ethidium bromide with the isomeric deoxytetranucleoside triphosphates 5’-d(GpCpGpC) and 5’-d(CpGpCpG) in aqueous solution. J Chem Soc Faraday Trans 92: 3545-3557.
    [186] 62. Kostjukov VV, Pahomov VI, Andrejuk DD, et al. (2007) Investigation of the complexation of the anti-cancer drug novantrone with the hairpin structure of the deoxyheptanucleotide 5′-d(GpCpGpApApGpC). J Mol Struct 843: 78-86. doi: 10.1016/j.molstruc.2006.12.036
    [187] 63. Wartell RM, Benight AS (1985) Thermal denaturation of DNA molecules: A comparison of theory with experiment. Phys Rep 126: 67-107. doi: 10.1016/0370-1573(85)90060-2
    [188] 64. Rice SA, Doty P (1957) The Thermal Denaturation of Desoxyribose Nucleic Acid. J Am Chem Soc 79: 3937-3947. doi: 10.1021/ja01572a001
    [189] 65. Guedin A, Lacroix L, Mergny JL (2010) Thermal melting studies of ligand DNA interactions. Methods Mol Biol 613: 25-35. doi: 10.1007/978-1-60327-418-0_2
    [190] 66. Goldstein G, Stern KG (1950) Experiments on the sonic, thermal, and enzymic depolymerization of desoxyribosenucleic acid. J Struc Chem 5: 687-708.
    [191] 67. Thomas R (1954) Recherches sur la d'enaturation des acides desoxyribonucléiques. Biochimica et Biophysica Acta 14: 231-240. doi: 10.1016/0006-3002(54)90163-8
    [192] 68. Frank-Kamenetskii M (1965) Theory of the helix-coil transition for deoxyribonucleic acids with additional connections between the chains. Vysokomolekulyarnye Soedineniya 7: 354-361.
    [193] 69. Frank-Kamenetskii M (1968) Consideration of helix-coil transition in homopolymers by the most probable distribution method. Mol Biol 2: 408-419.
    [194] 70. Stewart CR (1968) Broadening by acridine orange of the thermal transition of DNA. Biopolymers 6: 1737-1743. doi: 10.1002/bip.1968.360061208
    [195] 71. Lazurkin YS, Frank-Kamenetskii MD, Trifonov EN (1970) Melting of DNA: its study and application as a research method. Biopolymers 9: 1253-1306. doi: 10.1002/bip.1970.360091102
    [196] 72. Barcelo F, Capo D, Portugal J (2002) Thermodynamic characterization of the multivalent binding of chartreusin to DNA. Nucleic Acids Res 30: 4567-4573. doi: 10.1093/nar/gkf558
    [197] 73. Zhong W, Yu JS, Liang Y (2003) Chlorobenzylidine-herring sperm DNA interaction: binding mode and thermodynamic studies. Spectrochim Acta A Mol Biomol Spectrosc 59: 1281-1288. doi: 10.1016/S1386-1425(02)00301-3
    [198] 74. Vardevanyan PO, Antonyan AP, Hambardzumyan LA, et al. (2013) Thermodynamic analysis of DNA complexes with methylene blue, ethidium bromide and Hoechst 33258. Biopolym. Cell 29: 515-520.
    [199] 75. Hajian R, Guan Huat T (2013) Spectrophotometric Studies on the Thermodynamics of the ds-DNA Interaction with Irinotecan for a Better Understanding of Anticancer Drug-DNA Interactions. J Spectrosc 2013: 1-8.
    [200] 76. Cooper A, Johnson CM (1994) Introduction to microcalorimetry and biomolecular energetics. Methods Mol Biol 22: 109-24.
    [201] 77. Rosgen J, Hinz HJ (1999) Theory and practice of DSC mesuarements on proteins. In: Kemp RB, editor. Handbook of Thermal Analysis and Calorimetry, Vol.4, From Macromolecules to Man, Amsterdam: Elsevier, 63-108.
    [202] 78. Bruylants G, Wouters J, Michaux C (2005) Differential scanning calorimetry in life science: thermodynamics, stability, molecular recognition and application in drug design. Curr Med Chem 12: 2011-. doi: 10.2174/0929867054546564
    [203] 79. Spink CH (2008) Differential scanning calorimetry. Methods Cell Biol 84: 115-141. doi: 10.1016/S0091-679X(07)84005-2
    [204] 80. Bereznyak EG, Gladkovskaya NA, Khrebtova AS, et al. (2009) Peculiarities of DNA-proflavine binding under different concentration ratios. Biophysics 54: 574-580. doi: 10.1134/S0006350909050030
    [205] 81. Garbett N (2011) The Use of Calorimetry to Study Ligand-DNA Interactions. In: Aldrich-Wright J, editor. Metallointercalators, Vienna: Springer, 299-324.
    [206] 82. Ising E (1925) Beitrag zur Theorie des Ferromagnetismus. Zeitschrift für Physik 31: 253-258. doi: 10.1007/BF02980577
    [207] 83. Poland DC, Scheraga HA (1970) The theory of helix coil transition, New York: Academic Press.
    [208] 84. Peyrard M, Bishop AR (1989) Statistical mechanics of a nonlinear model for DNA denaturation. Phys Rev Lett 62: 2755-2758.
    [209] 85. Dauxois T, Peyrard M, Bishop AR (1993) Entropy-driven DNA denaturation. Physical Review E 47: R44-R47.
    [210] 86. Dauxois T, Peyrard M, Bishop AR (1993) Dynamics and thermodynamics of a nonlinear model for DNA denaturation. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 47: 684-695.
    [211] 87. Grosberg AIU, Khokhlov AR (1994) Statistical physics of macromolecules, New York: AIP Press.
    [212] 88. Frank-Kamenetskii MD, Prakash S (2014) Fluctuations in the DNA double helix: A critical review. Phys Life Rev 11: 153-170.
    [213] 89. Cantor CR, Schimmel PR (1980) Biophysical chemistry. 3. The behavior of biological macromolecules, San Francisco, Freeman.
    [214] 90. Zimm BH, Bragg JK (1959) Theory of the Phase Transition between Helix and Random Coil in Polypeptide Chains. J Chem Phys 31: 526-535.
    [215] 91. Crothers DM (1971) Statistical thermodynamics of nucleic acid melting transitions with coupled binding equilibria. Biopolymers 10: 2147-2160.
    [216] 92. McGhee JD (1976) Theoretical calculations of the helix-coil transition of DNA in the presence of large, cooperatively binding ligands. Biopolymers 15: 1345-1375.
    [217] 93. Akhrem AA, Fridman AS, Lando D (1985) Theory of helix-coil transition of the heterogeneous DNA-heteroqeneous ligands complexes. Biopolym Cell 1: 171-179.
    [218] 94. Lando D (1994) A theoretical consideration of the influence of selective binding of small ligands on DNA helix-coil transition. J Biomol Struct Dyn 12: 343-354. doi: 10.1080/07391102.1994.10508744
    [219] 95. Akhrem AA, Lando D (1979) Influence of ligands characteristic of selective binding to a certain type of base pairs on DNA helix-coil transition I. Model. Theory. Mol Biol (Mosk) 13: 1098-1109.
    [220] 96. Akhrem AA, Lando D, Shpakovskii AG, et al. (1990) The effect of long-range interactions between adsorbed ligands on the DNA helix-coil transition. Mol Biol (Mosk) 24: 649-656.
    [221] 97. Lando D, Ivanova MA, Akhrem AA (1980) Effect of changes in the stoichiometry of DNA-ligand complexes during heat denaturation of DNA on helix-coil transition parameters. Mol Biol (Mosk) 14: 1281-1288.
    [222] 98. Karapetian AT, Mehrabian NM, Terzikian GA, et al. (1996) Theoretical treatment of melting of complexes of DNA with ligands having several types of binding sites on helical and single-stranded DNA. J Biomol Struct Dyn 14: 275-283. doi: 10.1080/07391102.1996.10508118
    [223] 99. Plum GE, Bloomfield VA (1990) Structural and electrostatic effects on binding of trivalent cations to double-stranded and single-stranded poly[d (AT)]. Biopolymers 29: 13-27. doi: 10.1002/bip.360290105
    [224] 100. Spink CH, Chaires JB (1997) Thermodynamics of the Binding of a Cationic Lipid to DNA. J Am Chem Soc 119: 10920-10928. doi: 10.1021/ja964324s
    [225] 101. Leng F, Chaires JB, Waring MJ (2003) Energetics of echinomycin binding to DNA. Nucleic Acids Res 31: 6191-6197. doi: 10.1093/nar/gkg826
    [226] 102. Pasic L, Sepcic K, Turk T, et al. (2001) Characterization of parazoanthoxanthin A binding to a series of natural and synthetic host DNA duplexes. Arch Biochem Biophys 393: 132-142. doi: 10.1006/abbi.2001.2469
    [227] 103. Portugal J, Cashman DJ, Trent JO, et al. (2005) A new bisintercalating anthracycline with picomolar DNA binding affinity. J Med Chem 48: 8209-8219. doi: 10.1021/jm050902g
    [228] 104. Liu Y-J, Wei X, Mei W-J, et al. (2007) Synthesis, characterization and DNA binding studies of ruthenium(II) complexes: [Ru(bpy)2(dtmi)]2+ and [Ru(bpy)2(dtni)]2+. Transit Metal Chem 32: 762-768. doi: 10.1007/s11243-007-0246-y
    [229] 105. Peng B, Chen X, Du KJ, et al. (2009) Synthesis, characterization and DNA-binding studies of ruthenium(II) mixed-ligand complexes containing dipyrido[1,2,5]oxadiazolo[3,4-b]quinoxaline. Spectrochim Acta A Mol Biomol Spectrosc 74: 896-901. doi: 10.1016/j.saa.2009.08.031
    [230] 106. Barcelo F, Portugal J (2004) Elsamicin A binding to DNA. A comparative thermodynamic characterization. FEBS Lett 576: 68-72.
    [231] 107. Barcelo F, Scotta C, Ortiz-Lombardia M, et al. (2007) Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences. Nucleic Acids Res 35: 2215-2226. doi: 10.1093/nar/gkm037
    [232] 108. Marky LA, Blumenfeld KS, Breslauer KJ (1983) Calorimetric and spectroscopic investigation of drug-DNA interactions. I. The binding of netropsin to poly d(AT). Nucleic Acids Res 11: 2857-2870.
    [233] 109. Remeta DP, Mudd CP, Berger RL, et al (1993) Thermodynamic characterization of daunomycin-DNA interactions: comparison of complete binding profiles for a series of DNA host duplexes. Biochemistry 32: 5064-5073. doi: 10.1021/bi00070a014
    [234] 110. Brandts JF, Lin LN (1990) Study of strong to ultratight protein interactions using differential scanning calorimetry. Biochemistry 29: 6927-6940.
    [235] 111. Barone G, Catanzano F, Del Vecchio P, et al. (1995) Differential scanning calorimetry as a tool to study protein-ligand interactions. Pure Appl Chem 67: 1867-1872.
    [236] 112. Dassie SA, Celej MS, Fidelio GD (2005) Protein Unfolding Coupled to Ligand Binding: Differential Scanning Calorimetry Simulation Approach. J Chem Educ 82: 85. doi: 10.1021/ed082p85
    [237] 113. Celej MS, Dassie SA, Gonzalez M, et al. (2006) Differential scanning calorimetry as a tool to estimate binding parameters in multiligand binding proteins. Anal Biochem 350: 277-284. doi: 10.1016/j.ab.2005.12.029
    [238] 114. Esposito D, Del Vecchio P, Barone G (2001) A thermodynamic study of herring protamine-DNA complex by differential scanning calorimetry. Phys Chem Chem Phys 3: 5320-5325. doi: 10.1039/b107218h
    [239] 115. Dukhopelnikov EV, Bereznyak EG, Khrebtova AS, et al. (2013) Determination of ligand to DNA binding parameters from two-dimensional DSC curves. J Therm Anal Calorim 111: 1817-1827. doi: 10.1007/s10973-012-2561-6
    [240] 116. Straume M, Freire E (1992) Two-dimensional differential scanning calorimetry: Simultaneous resolution of intrinsic protein structural energetics and ligand binding interactions by global linkage analysis. Anal Biochem 203: 259-268. doi: 10.1016/0003-2697(92)90311-T
    [241] 117. Freire E (1994) Statistical thermodynamic analysis of differential scanning calorimetry data: structural deconvolution of heat capacity function of proteins. Methods Enzymol 240: 502-530. doi: 10.1016/S0076-6879(94)40062-8
    [242] 118. Freire E (1995) Differential scanning calorimetry. Methods Mol Biol 40: 191-218.
    [243] 119. Marky LA, Breslauer KJ (1987) Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves. Biopolymers 26: 1601-1620. doi: 10.1002/bip.360260911
    [244] 120. Sturtevant JM (1987) Biochemical Applications of Differential Scanning Calorimetry. Annu Rev Phys Chem 38: 463-488. doi: 10.1146/annurev.pc.38.100187.002335
    [245] 121. Kawai Y (1999) Thermal transition profiles of bacteriophage T4 and its DNA. J Gen Appl Microbiol 45: 135-138. doi: 10.2323/jgam.45.135
    [246] 122. Tostesen E, Sandve GK, Liu F, et al. (2009) Segmentation of DNA sequences into twostate regions and melting fork regions. J Phys Condens Matter 21: 034109. doi: 10.1088/0953-8984/21/3/034109
    [247] 123. Duguid JG, Bloomfield VA, Benevides JM, et al. (1996) DNA melting investigated by differential scanning calorimetry and Raman spectroscopy. Biophys J 71: 3350-3360.
    [248] 124. Movileanu L, Benevides JM, Thomas GJ (2002) Determination of base and backbone contributions to the thermodynamics of premelting and melting transitions in B DNA. Nucleic Acids Res 30: 3767-3777. doi: 10.1093/nar/gkf471
    [249] 125. Dukhopelnikov EV (2014) Modeling of heat absorption curves for ligand-competitor-DNA triple system. Biophysical Bulletin 31: 49-58.
  • Reader Comments
  • © 2015 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(8980) PDF downloads(1507) Cited by(8)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog